Patent Assignment
Reel/Frame 030621/0094
Assignment of Assignor's Interest
Recorded: 2013-06-17
Pages: 4
Assignor
PRUD'HOMME, GERALD J.
Executed: 2013-06-13
Assignee
WANG, QINGHUA
30 BOND AVENUE, NORTH YORK, M3B 3R8, CANADA
Covered Property
(1)
GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 17, 2013
From: WANG, QINGHUA; PRUD'HOMME, GERALD J.
To: ST. MICHAEL'S HOSPITAL
Reel/Frame 030621/0026 →
Assignment of Assignor's Interest
Jun 17, 2013
From: ST. MICHAEL'S HOSPITAL
To: WANG, QINGHUA; PRUD'HOMME, GERALD J.
Reel/Frame 030621/0077 →
Assignment of Assignor's Interest
Dec 6, 2016
From: WANG, QINGHUA
To: HONG KONG INNOGEN PHARMACEUTICAL TECHNOLOGY CO. LTD.
Reel/Frame 040842/0649 →
Assignment of Assignor's Interest
Dec 28, 2020
From: HONG KONG INNOGEN PHARMACEUTICAL TECHNOLOGY CO. LTD.
To: KUNMING INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.
Reel/Frame 054759/0682 →
Change of Name
Oct 25, 2022
From: KUNMING INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.
To: GUANGZHOU INNOGEN PHARMCEUTICAL GROUP CO., LTD.
Reel/Frame 061767/0903 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 061767 Frame: 0903. Assignor(S) Hereby Confirms the Change of Name.
Jan 4, 2023
From: KUNMING INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.
To: GUANGZHOU INNOGEN PHARMACEUTICAL GROUP CO., LTD.
Reel/Frame 062273/0483 →